(Q30753625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Plasma stability of two glycosyl indolocarbazole antitumor agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Hervé Vezin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Jean-François Goossens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Mustapha Kouach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Gilbert Briand

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Brigitte Baldeyrou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Nicole Wattez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Christian Bailly

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

25-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

Topoisomerase I poisons and suppressors as anticancer drugs

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxyl) ethylamino-12,13-dihydro-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione]] against pediatric and adult central nerv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

The Camptothecin-Resistant Topoisomerase I Mutant F361S Is Cross-Resistant to Antitumor Rebeccamycin Derivatives. A Model for Topoisomerase I Inhibition by Indolocarbazoles†

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901418-1

10.1016/S0006-2952(02)01418-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12473375%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference